Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
StateWatch: Bill Review May/June 2019
Keep current with new legislation and its potential effect on your organization.
Auto Casualty
Article
Five Questions with Shahin Hatamian About the Future of Claims Automation
We sit down with Shahin Hatamian, SVP of Product Management and Strategy at Mitchell International, to discuss five ways that automation is current
Mitchell
Article
How Managing Provider Data Can Make a Positive Impact on the Claims Process
This is the third and final article in a series about provider data quality.
Workers' Comp
Blog
What Will Opioid Legislation do for Pharmacy and Opioid Risk Management?
In October 2018, Congress passed H.R.6, the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communitie
Mitchell
Article
Frequency and Severity Trends in Auto Claims
In late 2018, three of the largest auto insurers in the United States reported decreased frequency and increased severity in third quarter auto cla
Mitchell
Article